Cargando…
Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus
Early reports indicate that metformin, a clinical drug administered to treat type 2 diabetes mellitus (T2DM), was found to be associated with a better prognosis of cancer. The objective of this study was retrospectively analyzed the effect of metformin on the outcomes of Chinese breast cancer patien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113316/ https://www.ncbi.nlm.nih.gov/pubmed/33976288 http://dx.doi.org/10.1038/s41598-021-89475-y |